ATE480265T1 - Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen - Google Patents

Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen

Info

Publication number
ATE480265T1
ATE480265T1 AT05786212T AT05786212T ATE480265T1 AT E480265 T1 ATE480265 T1 AT E480265T1 AT 05786212 T AT05786212 T AT 05786212T AT 05786212 T AT05786212 T AT 05786212T AT E480265 T1 ATE480265 T1 AT E480265T1
Authority
AT
Austria
Prior art keywords
fibroblas
dental
vascular cells
treat vascular
treat
Prior art date
Application number
AT05786212T
Other languages
English (en)
Inventor
Antoine Lafont
Bruno Gogly
Original Assignee
Univ Paris Descartes
Assist Publ Hopitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris Descartes, Assist Publ Hopitaux De Paris filed Critical Univ Paris Descartes
Application granted granted Critical
Publication of ATE480265T1 publication Critical patent/ATE480265T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05786212T 2004-07-02 2005-07-01 Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen ATE480265T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0407357A FR2872431B1 (fr) 2004-07-02 2004-07-02 Utilisation de fibroplastes gingivaux en therapie cellulaire vasculaire
PCT/FR2005/001690 WO2006013261A2 (fr) 2004-07-02 2005-07-01 Utilisation de fibroblastes gingivaux en therapie cellulaire vasculaire.

Publications (1)

Publication Number Publication Date
ATE480265T1 true ATE480265T1 (de) 2010-09-15

Family

ID=34946541

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05786212T ATE480265T1 (de) 2004-07-02 2005-07-01 Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen

Country Status (11)

Country Link
US (2) US8119122B2 (de)
EP (1) EP1773420B1 (de)
JP (1) JP4891903B2 (de)
AT (1) ATE480265T1 (de)
AU (1) AU2005268746B2 (de)
CA (1) CA2572554C (de)
DE (1) DE602005023468D1 (de)
DK (1) DK1773420T3 (de)
ES (1) ES2354220T3 (de)
FR (1) FR2872431B1 (de)
WO (1) WO2006013261A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2049164B1 (de) 2006-08-10 2017-12-27 Université Paris Descartes Verfahren zur behandlund von hautläsionen
US7951593B2 (en) * 2007-03-20 2011-05-31 Universite Rene Descartes-Paris V Culture medium for gingival fibroblasts
US9867971B2 (en) * 2007-10-09 2018-01-16 Assistance Publique—Hopitaux de Paris Device for administering cells and cell-therapy methods using said device
CA2719981A1 (en) * 2008-03-31 2009-10-08 Scarcell Therapeutics Method for the cosmetic treatment of skin ageing
US20120100111A1 (en) * 2009-03-06 2012-04-26 Universite Paris Descartes Method for treating cancer
WO2011012575A1 (en) 2009-07-27 2011-02-03 Scarcell Therapeutics Balloon catheter device
FR3008316B1 (fr) * 2013-07-09 2020-01-31 Assistance Publique - Hopitaux De Paris Utilisation de fibroblastes gingivaux dans le traitement de l'alopecie
JP7108537B2 (ja) * 2016-04-27 2022-07-28 ロート製薬株式会社 Ｃｄ２０１、ｃｄ４６、ｃｄ５６、ｃｄ１４７及びｃｄ１６５からなる群より選択される少なくとも１種の細胞表面マーカーを発現する間葉系幹細胞及びその調製方法、並びに上記間葉系幹細胞を含む医薬組成物及びその調製方法
EP3541399A1 (de) * 2016-11-18 2019-09-25 Scarcell Therapeutics Zusammensetzungen zur verwendung bei der behandlung von immunerkrankungen
EP3888756A4 (de) * 2018-11-30 2022-07-13 Shiseido Company, Ltd. Zusammensetzung zur behandlung oder vorbeugung von hautpigmentierung
US12351823B2 (en) 2023-03-15 2025-07-08 Scarcell Technologies Mammalian cell population and medicaments for cell therapies in equines and improved cell cultivation methods
WO2024189522A1 (en) 2023-03-15 2024-09-19 Scarcell Therapeutics Mammalian cell population and medicaments for cell therapies in mammals and improved cell cultivation methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2678945B2 (ja) * 1989-04-17 1997-11-19 有限会社ナイセム 人工血管とその製造方法及び人工血管用基質
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
AU3214797A (en) * 1996-05-28 1998-01-05 Regents Of The University Of Michigan, The Engineering oral tissues
WO1999051164A1 (en) * 1998-04-03 1999-10-14 Reprogenesis, Inc. Soft tissue reconstructor and method of use
AU2001249704A1 (en) * 2000-04-28 2001-11-12 The Regents Of The University Of California Structures useful for bone engineering and methods
US20040101959A1 (en) * 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells

Also Published As

Publication number Publication date
WO2006013261A2 (fr) 2006-02-09
EP1773420B1 (de) 2010-09-08
US8119122B2 (en) 2012-02-21
EP1773420A2 (de) 2007-04-18
JP4891903B2 (ja) 2012-03-07
CA2572554A1 (fr) 2006-02-09
DK1773420T3 (da) 2011-01-10
DE602005023468D1 (de) 2010-10-21
JP2008505164A (ja) 2008-02-21
FR2872431A1 (fr) 2006-01-06
US8609085B2 (en) 2013-12-17
US20120177613A1 (en) 2012-07-12
CA2572554C (fr) 2013-09-10
FR2872431B1 (fr) 2007-07-20
US20080025954A1 (en) 2008-01-31
WO2006013261A3 (fr) 2006-06-15
ES2354220T3 (es) 2011-03-11
AU2005268746B2 (en) 2011-01-06
AU2005268746A1 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
ATE544748T1 (de) Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen
ATE439863T1 (de) Ophthalmische zusammensetzungen von parasympathischen stimulantia und entzündungshemmer zur verwendung bei der behandlung von presbyopie
ATE554725T1 (de) Chirurgische artikel zur behandlung von beckenerkrankungen
ATE530142T1 (de) Chirurgische artikel zur behandlung von beckenerkrankungen
ATE523196T1 (de) Mitotische kinesinhemmer und verfahren zu ihrer verwendung
DE602006018354D1 (de) Verfahren zur behandlung von abnormalem zellwachstum
DE602004028587D1 (de) ZUSAMMENSETZUNGEN UND VERFAHREN ZUR siRNA-HEMMUNG VON ICAM-1
ATE471334T1 (de) Phosphoramidatderivate von nukleosidverbindungen zur verwendung bei der behandlung von krebs
ATE555380T1 (de) Verfahren zur änderung des schicksals von zellen
DE112005001005A5 (de) Biokompatible Beschichtung, Verfahren und Verwendung von medizinischen Oberflächen
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE531340T1 (de) Ballon-expandierbarer stent und herstellungsverfahren dafür
DE60335608D1 (de) Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
DE602005015862D1 (de) Verwendung von k-252a und kinasehemmern zur vorbeugung und behandlung von hmgb1-assoziierten pathologien
EP1742675A4 (de) Behandlung von biomedizinischem abfall
ATE480265T1 (de) Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen
DE60136826D1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
DE602005019247D1 (de) Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen
ATE487487T1 (de) Verwendung von verbindungen, die die ef-tu- nucleolin wechselwirkung vehindern, zur verhinderung oder behandlung von tularämie
DK1438034T3 (da) Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens
DE602005015160D1 (de) Stent-Graft zur Behandlung von Aneurysmen
DE602005021766D1 (de) Verfahren zur behandlung von atherosklerose
ATE397000T1 (de) Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties